BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Actemra tocilizumab regulatory update

FDA approved an expanded label for Actemra tocilizumab from Roche to include the treatment of systemic juvenile idiopathic arthritis. Roche also disclosed in its 1Q11 earnings that it submitted an application in...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >